Loading...
Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats
BACKGROUND: Cyclosporin A (CsA) is a promising therapeutic drug for myocardial ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of mitochondrial permeability transition pore (mPTP). However, the application of cyclosporin A to treat MI/RI is limited due to its im...
Na minha lista:
| Udgivet i: | J Nanobiotechnology |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6346555/ https://ncbi.nlm.nih.gov/pubmed/30683110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-019-0451-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|